Paper12475985
Inhibition of cdk2 activating phosphorylation by mevastatin.
Ukomadu C and 1 other. J Biol Chem, 2003. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of cdk2 activating phosphorylation by mevastatin. Papers, record 12475985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12475985
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anticholesteremic Agents | Major topic |
| CDC2-CDC28 Kinases | Major topic |
| Cyclin-Dependent Kinases | Major topic |
| Lovastatin | Major topic |
| Protein Serine-Threonine Kinases | Major topic |
| Cell Division | |
| Cyclin-Dependent Kinase 2 | |
| Enzyme Activation | |
| Humans | |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | |
| Male | |
| Phosphorylation | |
| Prostatic Neoplasms | |
| Tumor Cells, Cultured |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01-CA89406 | NCI NIH HHS | United States | R01CA089406 | PubMed and NIH |
Source NIH RePORTER
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40358525 | Cdk activation by phosphorylation: linking growth signals to cell cycle control. | Biochem Soc Trans | 2025 | https://conductscience.org/library/papers/40358525 | PubMed |
| 38893271 | Cholesterol Dietary Intake and Tumor Cell Homeostasis Drive Early Epithelial Tumorigenesis: A Potential Modelization of Early Prostate Tumorigenesis. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38893271 | PubMed |
| 28130224 | CYP27A1 Loss Dysregulates Cholesterol Homeostasis in Prostate Cancer. | Cancer Res | 2017 | https://conductscience.org/library/papers/28130224 | PubMed |
| 26225745 | Targeted disruption of fibrinogen like protein-1 accelerates hepatocellular carcinoma development. | Biochem Biophys Res Commun | 2015 | https://conductscience.org/library/papers/26225745 | PubMed |
| 25916848 | RPA70 depletion induces hSSB1/2-INTS3 complex to initiate ATR signaling. | Nucleic Acids Res | 2015 | https://conductscience.org/library/papers/25916848 | PubMed |
| 24389535 | The strategies to control prostate cancer by chemoprevention approaches. | Mutat Res | 2014 | https://conductscience.org/library/papers/24389535 | PubMed |
| 23483972 | Targeted deletion of fibrinogen like protein 1 reveals a novel role in energy substrate utilization. | PLoS One | 2013 | https://conductscience.org/library/papers/23483972 | PubMed |
| 22072796 | UHRF1 phosphorylation by cyclin A2/cyclin-dependent kinase 2 is required for zebrafish embryogenesis. | Mol Biol Cell | 2012 | https://conductscience.org/library/papers/22072796 | PubMed |
| 21214517 | UHRF1 depletion causes a G2/M arrest, activation of DNA damage response and apoptosis. | Biochem J | 2011 | https://conductscience.org/library/papers/21214517 | PubMed |
| 20190811 | Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells. | Oncogene | 2010 | https://conductscience.org/library/papers/20190811 | PubMed |
| 18947424 | The prince and the pauper. A tale of anticancer targeted agents. | Mol Cancer | 2008 | https://conductscience.org/library/papers/18947424 | PubMed |
| 18679777 | Simvastatin inducing PC3 prostate cancer cell necrosis mediated by calcineurin and mitochondrial dysfunction. | J Bioenerg Biomembr | 2008 | https://conductscience.org/library/papers/18679777 | PubMed |
| 17092340 | Regulation of CDK4. | Cell Div | 2006 | https://conductscience.org/library/papers/17092340 | PubMed |
| 16782892 | Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors". | Mol Cell Biol | 2006 | https://conductscience.org/library/papers/16782892 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CDK2 | 1017 | PubTator's text mining | https://conductscience.org/library/genes/1017 | NCBI Gene |
| CDK7 | 1022 | PubTator's text mining | https://conductscience.org/library/genes/1022 | NCBI Gene |
| CDKN1C | 1028 | PubTator's text mining | https://conductscience.org/library/genes/1028 | NCBI Gene |
| DCTN6 | 10671 | PubTator's text mining | https://conductscience.org/library/genes/10671 | NCBI Gene |
| H3P16 | 644914 | PubTator's text mining | https://conductscience.org/library/genes/644914 | NCBI Gene |
| MNAT1 | 4331 | PubTator's text mining | https://conductscience.org/library/genes/4331 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12475985
GET https://conductscience.org/api/papers/v1/12475985/authors